{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:26:11Z","timestamp":1785529571445,"version":"3.56.0"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.micpath.2024.107236","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:39:19Z","timestamp":1734482359000},"page":"107236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Recent advances in TGF-\u03b2 signaling pathway in COVID-19 pathogenesis: A review"],"prefix":"10.1016","volume":"199","author":[{"given":"Mahdi","family":"Majidpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ghader","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Davodabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Sabeti Akbar-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-5977","authenticated-orcid":false,"given":"Saman","family":"Sargazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Shahriari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.107236_bib1","first-page":"86","article-title":"Convalescent plasma therapy for COVID-19: lessons from SARS-CoV, MERS-CoV, and H1N1 infection","volume":"53","author":"Hosseini","year":"2021","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.micpath.2024.107236_bib2","first-page":"26","article-title":"Relationship between blood groups and the risk of Covid-19 infection; a cohort study","volume":"17","author":"Mahjoor","year":"2024","journal-title":"J. Med. Bacteriol."},{"key":"10.1016\/j.micpath.2024.107236_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s10787-022-01029-4","article-title":"Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients","volume":"30","author":"Ghaznavi","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.micpath.2024.107236_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2024.107236_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.idc.2019.07.001","article-title":"Severe acute respiratory syndrome: historical, epidemiologic, and clinical features","volume":"33","author":"Hui","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.micpath.2024.107236_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.idc.2019.08.001","article-title":"The Middle East respiratory syndrome (MERS)","volume":"33","author":"Azhar","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.micpath.2024.107236_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01625-0","article-title":"An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19","volume":"20","author":"Yasamineh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib8","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1007\/s12010-022-03885-w","article-title":"Association of TMPRSS2 gene polymorphisms with COVID-19 severity and mortality: a case-control study with computational analyses","volume":"194","author":"Rokni","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40268-020-00312-5","article-title":"Identification of a potential peptide inhibitor of SARS-CoV-2 targeting its entry into the host cells","volume":"20","author":"Baig","year":"2020","journal-title":"Drugs R"},{"key":"10.1016\/j.micpath.2024.107236_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211048026","article-title":"A scoping review of the pathophysiology of COVID-19","volume":"35","author":"Marik","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131324","article-title":"An unprecedented global challenge, emerging trends and innovations in the fight against COVID-19: a comprehensive review","author":"Moneshwaran","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2024.107236_bib12","first-page":"1","article-title":"Angiotensin-converting enzyme-2 (ACE2) downregulation during coronavirus infection","volume":"13","author":"Nor Rashid","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/biom13050787","article-title":"Role of angiotensin II in cardiovascular diseases: introducing bisartans as a novel therapy for coronavirus 2019","volume":"13","author":"Swiderski","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2024.107236_bib14","doi-asserted-by":"crossref","first-page":"L246","DOI":"10.1152\/ajplung.00423.2020","article-title":"In well-differentiated primary human bronchial epithelial cells, TGF-\u03b2 1 and TGF-\u03b2 2 induce expression of furin","volume":"320","author":"O'Sullivan","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.micpath.2024.107236_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/jir.2021.0222","article-title":"Possible role of matrix metalloproteinases and TGF-\u03b2 in COVID-19 severity and sequelae","volume":"42","author":"Ram\u00edrez-Mart\u00ednez","year":"2022","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2024.107236_bib16","article-title":"Immune responses in COVID-19 patients: insights into cytokine storms and adaptive immunity kinetics","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2024.107236_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106239","article-title":"Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians","volume":"176","author":"Batah","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/ijms23010168","article-title":"COVID-19: immunohistochemical analysis of TGF-\u03b2 signaling pathways in pulmonary fibrosis","volume":"23","author":"Vaz de Paula","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022129","article-title":"Non-smad signaling pathways of the TGF-\u03b2 family","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","article-title":"TGF-beta: a master immune regulator","volume":"24","author":"Larson","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.micpath.2024.107236_bib21","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.4049\/jimmunol.172.12.7841","article-title":"Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep25359","article-title":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity","volume":"6","author":"Min","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155323","article-title":"Cytokine profile and disease severity in patients with COVID-19","volume":"137","author":"Ghazavi","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2024.107236_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.748931","article-title":"Common molecular pathways between post-COVID19 syndrome and lung fibrosis: a scoping review","volume":"13","author":"Bergantini","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/biomedicines12030639","article-title":"The role of cytokines and Molecular pathways in Lung Fibrosis following SARS-CoV-2 infection: a physiopathologic (re) view","volume":"12","author":"Lazar","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.micpath.2024.107236_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512412","article-title":"Epithelial\u2013mesenchymal transition mechanisms in chronic airway diseases: a common process to target?","volume":"24","author":"Mottais","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350433","article-title":"Serum TGF\u2010\u03b2 as a predictive biomarker for severe disease and fatality of COVID\u201019","volume":"53","author":"Frischbutter","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1066375","article-title":"Dysregulation of the immune response in TGF-\u03b2 signalopathies","volume":"13","author":"Rodari","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/13543776.2024.2346325","article-title":"Targeting the TGF-\u03b2 signaling pathway: an updated patent review (2021\u2013present)","volume":"34","author":"Guo","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.micpath.2024.107236_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrg2417","article-title":"EvoD\/Vo: the origins of BMP signalling in the neuroectoderm","volume":"9","author":"Mizutani","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.micpath.2024.107236_bib31","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1016\/j.cub.2009.11.021","article-title":"Extracellular regulation of BMP signaling","volume":"20","author":"Zakin","year":"2010","journal-title":"Curr. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib32","doi-asserted-by":"crossref","first-page":"14806","DOI":"10.1074\/jbc.M109.079921","article-title":"Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily","volume":"285","author":"Radaev","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107236_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111780","article-title":"The miR-103a-3p\/TGFBR3 axis regulates TGF-\u03b2-induced orbital fibroblast activation and fibrosis in thyroid-eye disease","volume":"559","author":"Xie","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.micpath.2024.107236_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fphar.2019.00204","article-title":"Anti-inflammatory effects of traditional Chinese medicines on preclinical in vivo models of brain ischemia-reperfusion-injury: prospects for neuroprotective drug discovery and therapy","volume":"10","author":"Peng","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biom10030487","article-title":"TGF-\u0392 signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2024.107236_bib36","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022111","article-title":"Structural basis of intracellular TGF-\u03b2 signaling: receptors and smads","volume":"8","author":"Chaikuad","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2015.10.006","article-title":"Growth and differentiation factor 11 (GDF11): functions in the regulation of erythropoiesis and cardiac regeneration","volume":"156","author":"Rochette","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2024.107236_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biom10030487","article-title":"TGF-\u0392 signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2024.107236_bib39","article-title":"Viruses as key modulators of the TGF-\u03b2 pathway; a double-edged sword involved in cancer","volume":"28","author":"Mirzaei","year":"2018"},{"key":"10.1016\/j.micpath.2024.107236_bib40","series-title":"Seminars in Cancer Biology","first-page":"136","article-title":"TGF-\u03b2 in developmental and fibrogenic EMTs","author":"Lee","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-beta superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.micpath.2024.107236_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression","volume":"10","author":"Ikushima","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.micpath.2024.107236_bib43","first-page":"158","volume":"vol. 66","author":"Huang","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib44","volume":"vol. 2021","author":"Yang","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000057360","article-title":"Mechanisms of TGF-beta-induced cell cycle arrest","volume":"24","author":"Hocevar","year":"1998","journal-title":"Miner. Electrolyte Metab."},{"key":"10.1016\/j.micpath.2024.107236_bib46","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1529\/biophysj.107.119891","article-title":"TGFbeta\/Activin\/Nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain","volume":"94","author":"Saha","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.micpath.2024.107236_bib47","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022053","article-title":"Signaling receptors for TGF-\u03b2 family members","volume":"8","author":"Heldin","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022145","article-title":"TGF-\u0392 family signaling in the control of cell proliferation and survival","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib50","first-page":"39","volume":"vol. 23","author":"Sun","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib51","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1038\/sj.onc.1208475","article-title":"Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy","volume":"24","author":"Romero-Gallo","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.micpath.2024.107236_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.10066","article-title":"Regulation of cell proliferation by Smad proteins","volume":"191","author":"Ten Dijke","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.micpath.2024.107236_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780903382609","article-title":"Targeting the transforming growth factor-beta signaling pathway in human cancer","volume":"19","author":"Nagaraj","year":"2010","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.micpath.2024.107236_bib54","volume":"vol. 10","author":"Dahmani","year":"2018"},{"key":"10.1016\/j.micpath.2024.107236_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib56","volume":"vol. 12","author":"Roufayel","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib57","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/embor.2008.158","article-title":"TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2","volume":"9","author":"Ramesh","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/cc.8.1.7291","article-title":"Transforming growth factor beta (TGFbeta)-induced apoptosis: the rise & fall of Bim","volume":"8","author":"Ramesh","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.micpath.2024.107236_bib59","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib60","volume":"vol. 10","author":"Kim","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3727\/000000001783992560","article-title":"Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells","volume":"9","author":"Lynch","year":"2001","journal-title":"Gene Expr."},{"key":"10.1016\/j.micpath.2024.107236_bib62","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jconrel.2022.07.036","article-title":"Breast cancer vaccines: new insights into immunomodulatory and nano-therapeutic approaches","volume":"349","author":"Davodabadi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2024.107236_bib63","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1166\/jnn.2015.11692","article-title":"Adjuvant effect of biogenic selenium nanoparticles improves the immune responses and survival of mice receiving 4T1 cell antigens as vaccine in breast cancer murine model","volume":"15","author":"Yazdi","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib64","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0014-5793(01)02113-5","article-title":"Growth factor-dependent signaling and cell cycle progression","volume":"490","author":"Jones","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.micpath.2024.107236_bib65","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.micpath.2024.107236_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112906","article-title":"Diterpenoid alkaloids isolated from Delphinium trichophorum alleviate pulmonary fibrosis via the TGF-\u03b2\/Smad pathway in 3T6 and HFL-1 cells","volume":"149","author":"Yao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2024.107236_bib67","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12931-022-02088-5","article-title":"Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation","volume":"23","author":"Qin","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.micpath.2024.107236_bib68","first-page":"5008","volume":"vol. 294","author":"Bahudhanapati","year":"2019"},{"key":"10.1016\/j.micpath.2024.107236_bib69","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-\u03b2 signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.micpath.2024.107236_bib70","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1074\/jbc.M506770200","article-title":"Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling","volume":"281","author":"Cho","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107236_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14728222.2018.1406922","article-title":"TGF\u03b2 as a therapeutic target in cystic fibrosis","volume":"22","author":"Kramer","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.micpath.2024.107236_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2017.11.004","article-title":"TGF\u03b2 pathway inhibition in the treatment of non-small cell lung cancer","volume":"184","author":"Eser","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2024.107236_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/abbs\/gmx126","article-title":"TGF-\u03b2 family co-receptor function and signaling","volume":"50","author":"Nickel","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.micpath.2024.107236_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/d0132de3-56ca-4258-9119-bdab0ceb2cff","article-title":"Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease","volume":"8","author":"Harris","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102509","article-title":"Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model","volume":"57","author":"Pei","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.micpath.2024.107236_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1513\/pats.201202-017AW","article-title":"Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast","volume":"9","author":"Hinz","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.micpath.2024.107236_bib78","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1053-2498(98)00024-2","article-title":"Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis","volume":"18","author":"El-Gamel","year":"1999","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.micpath.2024.107236_bib79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.resp.2013.09.011","article-title":"Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice","volume":"190","author":"Shi","year":"2014","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.micpath.2024.107236_bib80","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/annrheumdis-2022-eular.3265","article-title":"Pos0484 Lung Organoids: a novel approach to study the molecular pathology of pulmonary fibrosis in systemic sclerosis","volume":"81","author":"Aspari","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.micpath.2024.107236_bib81","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/jcmm.12298","article-title":"TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons","volume":"18","author":"Kandasamy","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/S0012-3692(15)38703-1","article-title":"Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?","volume":"120","author":"Roberts","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.micpath.2024.107236_bib83","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1165\/ajrcmb.21.6.3719","article-title":"Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis","volume":"21","author":"Allen","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib84","article-title":"Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib85","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.114.222372","article-title":"High-mobility group box 1 mediates epithelial-to-mesenchymal transition in pulmonary fibrosis involving transforming growth factor-\u03b21\/smad2\/3 signaling","volume":"354","author":"Li","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.micpath.2024.107236_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109316","article-title":"Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b21 signaling pathway","volume":"113","author":"Chen","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2024.107236_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115031","article-title":"Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-\u03b2 signaling pathway as revealed by UPLC-Q-TOF\/MS, network pharmacology and experimental verification","volume":"289","author":"Wu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib88","article-title":"Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK\/STAT and TGFB signaling pathways","volume":"22","author":"Aydemir","year":"2021","journal-title":"Gene Rep"},{"key":"10.1016\/j.micpath.2024.107236_bib89","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/v14112466","article-title":"TGF-\u0392 from the porcine intestinal cell line IPEC-J2 induced by porcine circovirus 2 increases the frequency of Treg cells via the activation of ERK (in CD4(+) T cells) and NF-\u03baB (in IPEC-J2)","volume":"14","author":"Liu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2024.107236_bib90","first-page":"759","volume":"vol. 55","author":"Thomas","year":"2016"},{"key":"10.1016\/j.micpath.2024.107236_bib91","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1128\/jvi.70.12.8624-8629.1996","article-title":"Influenza virus neuraminidase activates latent transforming growth factor beta","volume":"70","author":"Schultz-Cherry","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2024.107236_bib92","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-021-03159-9","article-title":"Virus infection induced pulmonary fibrosis","volume":"19","author":"Huang","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib93","volume":"vol. 14","author":"Martin","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib94","volume":"vol. 21","author":"Lorenzo","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib95","volume":"vol. 95","author":"Kang","year":"2023"},{"key":"10.1016\/j.micpath.2024.107236_bib96","first-page":"1123","volume":"vol. 9","author":"Han","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.677008","article-title":"Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action?","volume":"12","author":"Islam","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib99","volume":"vol. 13","author":"D'Amico","year":"2024"},{"key":"10.1016\/j.micpath.2024.107236_bib100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1684\/ecn.2019.0434","article-title":"IL-10 induces TGF-\u03b2 secretion, TGF-\u03b2 receptor II upregulation, and IgA secretion in B cells","volume":"30","author":"Bagheri","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.micpath.2024.107236_bib101","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fimmu.2018.01364","article-title":"Transforming growth factor-\u03b2 and interleukin-10 synergistically regulate humoral immunity via modulating metabolic signals","volume":"9","author":"Komai","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","article-title":"A potential role of interleukin 10 in COVID-19 pathogenesis","volume":"42","author":"Lu","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2009.06.015","article-title":"Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo","volume":"31","author":"Tinoco","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2024.107236_bib104","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s13258-022-01333-x","article-title":"Transcriptional induction of TGF-\u03b21 and endothelial-to-mesenchymal transition cell markers in human umbilical vein endothelial cells by Ebola virus infection","volume":"44","author":"Ro","year":"2022","journal-title":"Genes Genomics"},{"key":"10.1016\/j.micpath.2024.107236_bib105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/aid.2021.0212","article-title":"SMAD2\/3 phosphorylation is downregulated in T cells in HIV-infected patients","volume":"39","author":"Su","year":"2023","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.micpath.2024.107236_bib106","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/v14081823","article-title":"CMV and EBV Co-infection in HIV-infected children: infection rates and analysis of differential expression of cytokines in HIV mono- and HIV-CMV-EBV Co-infected groups","volume":"14","author":"Nazim","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2024.107236_bib107","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1128\/jvi.68.9.5730-5737.1994","article-title":"Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1","volume":"68","author":"Michelson","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2024.107236_bib108","first-page":"393","article-title":"Hypovitaminosis-D in chronic Hepatitis C patients: prevalence, relation to TGF-B1 and effect of viral eradication","volume":"54","author":"Abdelghani","year":"2022","journal-title":"Kuwait Med. J."},{"key":"10.1016\/j.micpath.2024.107236_bib109","first-page":"141","article-title":"Circulating transforming growth factor-\u03b2 and epidermal growth factor receptor as related to virus infection in liver carcinogenesis","volume":"32","author":"Divella","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.micpath.2024.107236_bib110","article-title":"The RBD of the spike protein of SARS-group coronaviruses is A highly specific target of SARS-CoV-2 antibodies but not other pathogenic human and animal coronavirus antibodies","volume":"10","author":"Premkumar","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.micpath.2024.107236_bib111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib112","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/embor.2010.191","article-title":"MicroRNA evolution by arm switching","volume":"12","author":"Griffiths-Jones","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib113","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ygeno.2020.09.059","article-title":"Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection","volume":"113","author":"Rahimi","year":"2021","journal-title":"Genomics"},{"key":"10.1016\/j.micpath.2024.107236_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108576","article-title":"Interferon gamma, TGF-\u03b21 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients","volume":"220","author":"Montalvo Villalba","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib115","first-page":"2190","volume":"vol. 9","author":"Leung","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib116","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pulmoe.2020.10.013","article-title":"Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis","volume":"27","author":"Torres-Castro","year":"2021","journal-title":"Pulmonology"},{"key":"10.1016\/j.micpath.2024.107236_bib117","article-title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-\u03b21 via ROS\/p38 MAPK\/STAT3 pathway","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib118","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","article-title":"IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4","volume":"181","author":"Avery","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib119","volume":"vol. 10","author":"Vaz de Paula","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib120","first-page":"682","volume":"vol. 588","author":"Barnes","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib121","article-title":"Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-\u03b2\/Smad3-NF.\u03baB-dependent mechanisms in mice","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib122","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/diagnostics12092051","article-title":"The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?","volume":"12","author":"Babalghith","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.micpath.2024.107236_bib123","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1080\/02648725.2022.2122291","article-title":"An insight into the placental growth factor (PlGf)\/angii axis in Covid-19: a detrimental intersection","volume":"40","author":"Al-Kuraishy","year":"2024","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.micpath.2024.107236_bib124","article-title":"COVID-19 in relation to hyperglycemia and diabetes mellitus","volume":"8","author":"Al-Kuraishy","year":"2021","journal-title":"Front.Crdiovascul.Med."},{"key":"10.1016\/j.micpath.2024.107236_bib125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.micpath.2024.107236_bib126","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1074\/jbc.M708033200","article-title":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling","volume":"283","author":"Zhao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2024.107236_bib127","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/pmic.201200225","article-title":"Correlation between TGF-\u03b21 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease","volume":"12","author":"Li","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.micpath.2024.107236_bib128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.virusres.2017.04.008","article-title":"SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-\u03b21 signaling","volume":"235","author":"Wang","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2024.107236_bib129","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2020.1805997","article-title":"HMGB1 enhances epithelial permeability via p63\/TGF-\u03b2 signaling in lung and terminal bronchial epithelial cells","volume":"8","author":"Kodera","year":"2020","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.micpath.2024.107236_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155496","article-title":"Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication","volume":"142","author":"Gowda","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.micpath.2024.107236_bib131","doi-asserted-by":"crossref","first-page":"E374","DOI":"10.1073\/pnas.1306798111","article-title":"TGF-\u03b2 directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury","volume":"111","author":"Peters","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.micpath.2024.107236_bib132","article-title":"Ion transport by pulmonary epithelia","volume":"2011","author":"Hollenhorst","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib133","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3389\/fimmu.2017.01644","article-title":"Cytokine-Ion channel interactions in pulmonary inflammation","volume":"8","author":"Hamacher","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib134","first-page":"43","volume":"vol. 38","author":"Freeberg","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","article-title":"Untimely TGF\u03b2 responses in COVID-19 limit antiviral functions of NK cells","volume":"600","author":"Witkowski","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2024.107236_bib136","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41467-021-22210-3","article-title":"SARS-CoV-2 in severe COVID-19 induces a TGF-\u03b2-dominated chronic immune response that does not target itself","volume":"12","author":"Ferreira-Gomes","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2024.107236_bib137","article-title":"Natural STAT3 inhibitors for cancer treatment: a comprehensive literature review","author":"Zarezadeh","year":"2023","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.micpath.2024.107236_bib138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","article-title":"TGF-beta signal transduction: biology, function and therapy for diseases","volume":"3","author":"Tie","year":"2022","journal-title":"Mol.Biomed."},{"key":"10.1016\/j.micpath.2024.107236_bib139","doi-asserted-by":"crossref","first-page":"726","DOI":"10.6026\/97320630010726","article-title":"Viral immune evasion in dengue: toward evidence-based revisions of clinical practice guidelines","volume":"10","author":"Chiappelli","year":"2014","journal-title":"Bioinformation"},{"key":"10.1016\/j.micpath.2024.107236_bib140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000442051","article-title":"Tgf\u03b2-induced actin cytoskeleton rearrangement in podocytes is associated with compensatory adaptation of mitochondrial energy metabolism","volume":"131","author":"Casalena","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.micpath.2024.107236_bib141","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/jir.1997.17.185","article-title":"Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na+\/K(+)-ATPase in FRTL-5 rat thyroid cells","volume":"17","author":"Pekary","year":"1997","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.micpath.2024.107236_bib142","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/08977194.2015.1010645","article-title":"The immune suppressive function of transforming growth factor-\u03b2 (TGF-\u03b2) in human diseases","volume":"33","author":"Sheng","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.micpath.2024.107236_bib143","first-page":"570","article-title":"TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells","volume":"66","author":"Jin","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.micpath.2024.107236_bib144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0896-6273(93)90319-M","article-title":"Peptide growth factor control of olfactory neurogenesis and neuron survival in vitro: roles of EGF and TGF-beta s","volume":"10","author":"Mahanthappa","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.micpath.2024.107236_bib145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijdevneu.2014.06.017","article-title":"Cellular and molecular mechanisms regulating embryonic neurogenesis in the rodent olfactory epithelium","volume":"37","author":"Kam","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.micpath.2024.107236_bib146","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-8993(02)02805-6","article-title":"Expression of TGF-beta type II receptors in the olfactory epithelium and their regulation in TGF-alpha transgenic mice","volume":"945","author":"Getchell","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.micpath.2024.107236_bib147","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12016-021-08848-3","article-title":"A review of persistent post-COVID syndrome (PPCS)","volume":"64","author":"Oronsky","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib148","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.7150\/ijbs.46891","article-title":"A potential treatment of COVID-19 with TGF-\u03b2 blockade","volume":"16","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib149","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.7150\/ijbs.46891","article-title":"A potential treatment of COVID-19 with TGF-\u03b2 blockade","volume":"16","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/oli.2006.0053","article-title":"Inhibition of TGF-\u03b2 2 with ap 12009 in recurrent malignant gliomas: from preclinical to phase I\/II studies","volume":"17","author":"Hau","year":"2007","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.micpath.2024.107236_bib151","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cytogfr.2005.09.002","article-title":"Targeted tumor therapy with the TGF-\u03b22 antisense compound AP 12009","volume":"17","author":"Schlingensiepen","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micpath.2024.107236_bib152","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2174\/138920111798808266","article-title":"The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-\u03b22","volume":"12","author":"Jaschinski","year":"2011","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.micpath.2024.107236_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100513","article-title":"Targeting transforming growth factor beta signaling in metastatic osteosarcoma","author":"Ge","year":"2023","journal-title":"J.Bone Oncol."},{"key":"10.1016\/j.micpath.2024.107236_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo3603","article-title":"In vivo gene immunotherapy for cancer","volume":"14","author":"Mai","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/jamp.2023.0014","article-title":"A phase I study of TRK-250, a novel siRNA-based oligonucleotide, in patients with idiopathic pulmonary fibrosis","volume":"36","author":"Doi","year":"2023","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.micpath.2024.107236_bib156","first-page":"A5391","article-title":"A novel siRNA-based oligonucleotide, TRK-250, and its efficacy for treatment of idiopathic pulmonary fibrosis (IPF)","volume":"199","author":"Shibata","year":"2019","journal-title":"Am.Thor.Soc.Int.Conf.Abstr."},{"key":"10.1016\/j.micpath.2024.107236_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188899","article-title":"First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-\u03b22), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery","volume":"12","author":"Pfeiffer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib158","first-page":"1937","article-title":"Targeting transforming growth factor beta 2 (TGF-\u03b22) isoform with isth0036-a potent and selective antisense oligonucleotide-for the treatment of glaucoma","volume":"67","author":"Hasenbach","year":"2003","journal-title":"Am. Fam. Physician"},{"issue":"8","key":"10.1016\/j.micpath.2024.107236_bib159","first-page":"321","article-title":"Long-term safety and efficacy of ISTH0036\u2013a selective TGF-\u03b22 blocking antisense oligonucleotide in preclinical and Phase 1 clinical studies","volume":"62","author":"Ruckert","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib160","series-title":"Effect on Tumor Growth by TGF-\u03921\/cox-2 siRNA Combination Product (STP705) in a Human Cholangiocarcinoma (HuCCT-1) Xenograft Tumor Model in Nude Mice","author":"Molyneaux","year":"2019"},{"key":"10.1016\/j.micpath.2024.107236_bib161","doi-asserted-by":"crossref","first-page":"AB156","DOI":"10.1016\/j.jaad.2020.06.712","article-title":"15580 Effect of TGF-\u03b21\/COX-2 small interfering RNA combination product (STP705) on cell viability and tumor growth in a human squamous carcinoma xenograft tumor model in nude mice","volume":"83","author":"Molyneaux","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.micpath.2024.107236_bib162","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1111\/cas.15461","article-title":"Antitumoral RNA\u2010targeted oligonucleotide therapeutics: the third pillar after small molecule inhibitors and antibodies","volume":"113","author":"Taniguchi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib163","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00018-014-1798-6","article-title":"EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-\u03b2\/Smad and ROS signaling","volume":"72","author":"Park","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib164","article-title":"TGF-\u03b21 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis","volume":"6","author":"Varricchio","year":"2021","journal-title":"JCI Isight"},{"key":"10.1016\/j.micpath.2024.107236_bib165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2020-140830","article-title":"Rationale for and results of a phase I study of the TGF-\u03b2 1\/3 inhibitor AVID200 in subjects with myelofibrosis: MPN-RC 118 trial","volume":"136","author":"Mascarenhas","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2024.107236_bib166","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15430\/JCP.2020.25.4.213","article-title":"Recent advances in the development of TGF-\u03b2 signaling inhibitors for anticancer therapy","volume":"25","author":"Lee","year":"2020","journal-title":"J.Cancer Prevent."},{"key":"10.1016\/j.micpath.2024.107236_bib167","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2018-99-116474","article-title":"AVID200, a potent trap for TGF-\u03b2 ligands inhibits TGF-\u03b21 signaling in human myelofibrosis","volume":"132","author":"Varricchio","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2024.107236_bib168","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.exphem.2020.11.002","article-title":"Inhibition of TGF\u03b21 and TGF\u03b23 promotes hematopoiesis in Fanconi anemia","volume":"93","author":"Rodr\u00edguez","year":"2021","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.micpath.2024.107236_bib169","article-title":"P856 AVID200, first-in-class TGF-beta1 and beta3 selective inhibitor: results of a phase 1 monotherapy dose escalation study in solid tumors and evidence of target engagement in patients","volume":"8","author":"Yap","year":"2020","journal-title":"J. Immun. Ther. Cancer"},{"key":"10.1016\/j.micpath.2024.107236_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib171","doi-asserted-by":"crossref","first-page":"9028","DOI":"10.1200\/jco.2008.26.15_suppl.9028","article-title":"Phase I\/II study of GC1008: a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)","volume":"26","author":"Morris","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micpath.2024.107236_bib172","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00280-017-3245-5","article-title":"A phase 1 study of anti-TGF\u03b2 receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors","volume":"79","author":"Tolcher","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib173","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1017\/erm.2022.37","article-title":"Roles of TGF-\u03b2 in cancer hallmarks and emerging onco-therapeutic design","volume":"24","author":"Dai","year":"2022","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib174","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/1078-0432.CCR-09-1634","article-title":"Anti\u2013transforming growth factor \u03b2 receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells","volume":"16","author":"Zhong","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.micpath.2024.107236_bib175","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1158\/1538-7445.AM2018-2790","article-title":"The anti-TGF\u03b2 neutralizing antibody, SAR439459, blocks the immunosuppressive effects of TGF\u03b2 and inhibits the growth of syngeneic tumors in combination with anti-PD1","volume":"78","author":"Gregory","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.micpath.2024.107236_bib176","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1811605","article-title":"Pan-TGF\u03b2 inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade","volume":"9","author":"Greco","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.micpath.2024.107236_bib177","series-title":"Safety and Efficacy Results from the Expansion Phase of the First-In-Human Study Evaluating TGF\u03b2 Inhibitor SAR439459 Alone and Combined with Cemiplimab in Adults with Advanced Solid Tumors","author":"Robbrecht","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib178","series-title":"In Patients (Pts) with Advanced Solid Tumors","article-title":"Phase Ib study of the anti-TGF-\u03b2 monoclonal antibody (mAb) NIS793 combined with spartalizumab (PDR001), a PD-1 inhibitor","author":"Bauer","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.04.113","article-title":"P-22 Phase III study (daNIS-2) of the anti\u2013TGF-\u03b2 monoclonal antibody NIS793 with nab-paclitaxel\/gemcitabine vs nab-paclitaxel\/gemcitabine alone in patients with first-line metastatic pancreatic ductal adenocarcinoma","volume":"33","author":"O'Reilly","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.micpath.2024.107236_bib180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8456","article-title":"Selective inhibition of TGF\u03b21 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape","volume":"12","author":"Martin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib181","article-title":"532 First-in-human phase 1 trial of SRK-181: a latent TGF\u03b21 inhibitor, alone or in combination with anti-PD-(L) 1 treatment in patients with advanced solid tumors (DRAGON trial)","volume":"9","author":"Yap","year":"2021","journal-title":"J. Immun. Ther. Cancer"},{"key":"10.1016\/j.micpath.2024.107236_bib182","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/1091581821998945","article-title":"Nonclinical development of SRK-181: an anti-latent TGF\u03b21 monoclonal antibody for the treatment of locally advanced or metastatic solid tumors","volume":"40","author":"Welsh","year":"2021","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.micpath.2024.107236_bib183","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS3146","article-title":"First-in-human phase 1 trial (DRAGON) of SRK-181, a potential first-in-class selective latent TGF\u03b21 inhibitor, alone or in combination with anti-PD-(L) 1 treatment in patients with advanced solid tumors","volume":"39","author":"Yap","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.micpath.2024.107236_bib184","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2024.107236_bib185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel mechanisms for the antifibrotic action of nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib186","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.3390\/ijms23158193","article-title":"Nintedanib inhibits endothelial mesenchymal transition in bleomycin-induced pulmonary fibrosis via focal adhesion kinase activity reduction","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib187","first-page":"203","volume":"vol. 19","author":"Yoon","year":"2018"},{"key":"10.1016\/j.micpath.2024.107236_bib188","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2018.11.012","article-title":"Lung function outcomes in the INPULSIS(\u00ae) trials of nintedanib in idiopathic pulmonary fibrosis","volume":"146","author":"Brown","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib189","volume":"vol. 22","author":"Grze\u015bk","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib190","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib191","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s43440-021-00255-x","article-title":"Role of pirfenidone in TGF-\u03b2 pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective","volume":"73","author":"Hamidi","year":"2021","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib192","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbrc.2007.01.012","article-title":"Pirfenidone inhibits TGF-\u03b2 expression in malignant glioma cells","volume":"354","author":"Burghardt","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2024.107236_bib193","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.200404-465SO","article-title":"Heme oxygenase-1: from bench to bedside","volume":"172","author":"Morse","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2024.107236_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26332\/seemedj.v7i1.268","article-title":"Anti-inflammatory and antioxidant response in COVID-19 infection: Nrf2\/HO-1 pathway","volume":"7","author":"Mari\u010di\u0107","year":"2023","journal-title":"Southeast. Eur. Med. J.: SEEMEDJ."},{"key":"10.1016\/j.micpath.2024.107236_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110242","article-title":"Heme oxygenase-1 (HO-1) cytoprotective pathway: a potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome","volume":"144","author":"Rossi","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.micpath.2024.107236_bib196","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00011-016-0973-7","article-title":"CORM-2 inhibits TXNIP\/NLRP3 inflammasome pathway in LPS-induced acute lung injury","volume":"65","author":"Jiang","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.micpath.2024.107236_bib197","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12890-017-0405-7","article-title":"Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2\/Bach1 equilibrium","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-12-24","article-title":"Pirfenidone inhibits TGF-\u03b21-induced over-expression of collagen type I and heat shock protein 47 in A549 cells","volume":"12","author":"Hisatomi","year":"2012","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib199","doi-asserted-by":"crossref","DOI":"10.3402\/ecrj.v2.26385","article-title":"Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine","volume":"2","author":"Myll\u00e4rniemi","year":"2015","journal-title":"Eur. Clin. Respir J."},{"key":"10.1016\/j.micpath.2024.107236_bib200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/CE.S76549","article-title":"Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy","volume":"11","author":"Margaritopoulos","year":"2016","journal-title":"Core Evid."},{"key":"10.1016\/j.micpath.2024.107236_bib201","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48593-4","article-title":"Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis","volume":"9","author":"Kato","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib202","volume":"vol. 14","author":"Bazdyrev","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/a-1300-2550","article-title":"The role of glucocorticoids in the management of COVID-19","volume":"53","author":"Alexaki","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.micpath.2024.107236_bib204","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/13880209.2016.1247879","article-title":"Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models","volume":"55","author":"Yu","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41598-017-18555-9","article-title":"A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis","volume":"8","author":"Roach","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.107236_bib206","first-page":"867","article-title":"The role of apoptosis in pulmonary fibrosis","volume":"19","author":"Kuwano","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.micpath.2024.107236_bib207","volume":"vol. 23","author":"Vaz de Paula","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib208","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI116771","article-title":"Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat","volume":"92","author":"Khalil","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micpath.2024.107236_bib209","doi-asserted-by":"crossref","first-page":"L162","DOI":"10.1152\/ajplung.00252.2005","article-title":"Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice","volume":"290","author":"Miller","year":"2006","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.micpath.2024.107236_bib210","volume":"vol. 14","author":"Hammond","year":"2019"},{"key":"10.1016\/j.micpath.2024.107236_bib211","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2017.00016","article-title":"Therapeutic efficacy of esomeprazole in cotton smoke-induced lung injury model","volume":"8","author":"Nelson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib212","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fphar.2018.00499","article-title":"Proton pump inhibitors in IPF: a call for clinical trials","volume":"9","author":"Ghebre","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","volume":"13","author":"Ghebremariam","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2024.107236_bib214","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/CS20120504","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.micpath.2024.107236_bib215","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.semnephrol.2020.01.005","article-title":"Histone deacetylases in kidney physiology and acute kidney injury","volume":"40","author":"Hyndman","year":"2020","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.micpath.2024.107236_bib216","first-page":"263","volume":"vol. 30","author":"Zhao","year":"2020"},{"key":"10.1016\/j.micpath.2024.107236_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841716","article-title":"HDAC inhibition as potential therapeutic strategy to restore the deregulated immune response in severe COVID-19","volume":"13","author":"Ripamonti","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib218","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09031936.00084808","article-title":"Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?","volume":"34","author":"Wang","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2024.107236_bib219","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbagrm.2018.03.007","article-title":"Suberanilohydroxamic acid prevents TGF-\u03b21-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation","volume":"1861","author":"Pasini","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Gene Regulat. Mechan."},{"key":"10.1016\/j.micpath.2024.107236_bib220","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2011-0040OC","article-title":"Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis","volume":"46","author":"Davies","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib221","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186615","article-title":"Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2024.107236_bib222","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2024.107236_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.671788","article-title":"Features of cytokine storm identified by distinguishing clinical manifestations in COVID-19","volume":"9","author":"Shen","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.micpath.2024.107236_bib224","first-page":"99","volume":"vol. 22","author":"Gheware","year":"2021"},{"key":"10.1016\/j.micpath.2024.107236_bib225","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1128\/MCB.01776-08","article-title":"Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis","volume":"29","author":"Coward","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1183\/09031936.00084808","article-title":"Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?","volume":"34","author":"Wang","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2024.107236_bib227","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbagrm.2018.03.007","article-title":"Suberanilohydroxamic acid prevents TGF-\u03b21-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation","volume":"1861","author":"Pasini","year":"2018","journal-title":"Biochimica Biophys. Acta Gene Regulat. Mechan."},{"key":"10.1016\/j.micpath.2024.107236_bib228","doi-asserted-by":"crossref","first-page":"L864","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.micpath.2024.107236_bib229","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2011-0040OC","article-title":"Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis","volume":"46","author":"Davies","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib230","volume":"vol. 132","author":"Jones","year":"2019"},{"key":"10.1016\/j.micpath.2024.107236_bib231","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10456-017-9543-z","article-title":"Effects of nintedanib on the microvascular architecture in a lung fibrosis model","volume":"20","author":"Ackermann","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.micpath.2024.107236_bib232","article-title":"Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment\u2013Evidence in disease-relevant in-vitro models","volume":"95","author":"Wang","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.micpath.2024.107236_bib233","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679388","article-title":"Evaluation of pirfenidone and nintedanib in a human lung model of fibrogenesis","volume":"12","author":"Roach","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib234","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.lfs.2007.11.003","article-title":"Pirfenidone inhibits the expression of HSP47 in TGF-\u03b21-stimulated human lung fibroblasts","volume":"82","author":"Nakayama","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.micpath.2024.107236_bib236","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","article-title":"Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial","volume":"13","author":"Kaffash Farkhad","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.micpath.2024.107236_bib237","volume":"vol. 11","author":"Rodr\u00edguez-Tom\u00e0s","year":"2022"},{"key":"10.1016\/j.micpath.2024.107236_bib238","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13046-018-0960-7","article-title":"Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-\u03b2 signaling in breast cancer","volume":"37","author":"Yao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.micpath.2024.107236_bib239","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/abbs\/gmq101","article-title":"Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms","volume":"42","author":"Wu","year":"2010","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.micpath.2024.107236_bib240","article-title":"A pharmacoinformatics analysis of artemisinin targets and de novo design of hits for treating ulcerative colitis","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107236_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2022.100956","article-title":"Identification of critical genes and pathways associated with hepatocellular carcinoma and type 2 diabetes mellitus using integrated bioinformatics analysis","volume":"30","author":"Maddah","year":"2022","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.micpath.2024.107236_bib242","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350433","article-title":"Serum TGF\u2010\u03b2 as a predictive biomarker for severe disease and fatality of COVID\u201019","volume":"53","author":"Frischbutter","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.micpath.2024.107236_bib243","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.jmb.2019.05.022","article-title":"Molecular engineering of the TGF-\u03b2 signaling pathway","volume":"431","author":"Zi","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2024.107236_bib244","article-title":"RGD-binding integrins and TGF-\u03b2 in SARS-CoV-2 infections - novel targets to treat COVID-19 patients?","volume":"10","author":"Carvacho","year":"2021"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024007034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401024007034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T19:26:53Z","timestamp":1737314813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401024007034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":244,"alternative-id":["S0882401024007034"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107236","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in TGF-\u03b2 signaling pathway in COVID-19 pathogenesis: A review","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107236"}}